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ABSTRACT
ObjectivesToestimatetherateofreportingofeuthanasia
cases to the Federal Control and Evaluation Committee
and to compare the characteristics of reported and
unreported cases of euthanasia.
Design Cross sectional analysis.
Setting Flanders, Belgium.
Participants A stratified at random sample was drawn of
people who died between 1 June 2007 and 30 November
2007. The certifying physician of each death was sent a
questionnaire on end of life decision making in the death
concerned.
Main outcome measures The rate of euthanasia cases
reportedtotheFederal Control andEvaluationCommittee;
physicians’ reasons for not reporting cases of euthanasia;
the relation between reporting and non-reporting and the
characteristics of the physician and patient; the time by
which life was shortened according to the physician; the
labelling of the end of life decision by the physician
involved; and differences in characteristics of due care
between reported and unreported euthanasia cases.
Results The survey response rate was 58.4% (3623/6202
eligible cases). The estimated total number of cases of
euthanasia in Flanders in 2007 was 1040 (95% CI 970 to
1109), thus the incidence of euthanasia was estimated as
1.9% of all deaths (95% CI 1.6% to 2.3%). Approximately
half (549/1040 (52.8%, 95% CI 43.9% to 60.5%)) of all
estimated cases of euthanasia were reported to the
FederalControlandEvaluationCommittee.Physicianswho
perceived their case as euthanasia reported it in 93.1%
(67/72) of cases. Cases of euthanasia were reported less
often when the time by which life was shortened was less
than one week compared with when the perceived life
shortening was greater (37.3% v 74.1%; P<0.001).
Unreported cases were generally dealt with less carefully
than reported cases: a written request for euthanasia was
more often absent (87.7% v 17.6% verbal request only;
P<0.001), other physicians and caregivers specialised in
palliative care were consulted less often (54.6% v 97.5%;
33.0% v 63.9%; P<0.001 for both), the life ending act was
more often performed with opioids or sedatives (92.1% v
4.4%; P<0.001), and the drugs were more often
administered by a nurse (41.3% v 0.0%; P<0.001).
Conclusions One out of two euthanasia cases is reported
to the Federal Control and Evaluation Committee. Most
non-reporting physicians do not perceive their act as
euthanasia. Countries debating legalisation of
euthanasiashouldsimultaneouslyconsiderdevelopinga
policy facilitating the due care and reporting obligations
of physicians.
INTRODUCTION
Medical end of life decisions including euthanasia, are
knowntooccurinseveralcountries.
12Belgiumis,along
with the Netherlands and Luxembourg, one of the few
placesintheworldwhereeuthanasiaislegal.Questions
concerning efficient societal control over euthanasia
and the prevention of abuse are at the forefront of the
debate over euthanasia.
3-6 The secrecy in which eutha-
nasia takesplace incountrieswhere itisillegal prevents
the development of standards for careful practice and
makessocietalcontroldifficult.
78However,legalisation
of euthanasia usually involves defining a standard for
careful medical practice and a system for societal
control.
9-12 Due care criteria were embedded in the law
when euthanasia was legalised in Belgium in 2002.
910
To make societal control over euthanasia possible, the
lawalso requiresphysicianswhoperform euthanasiato
report each case to the Federal Control and Evaluation
Committee(reviewcommittee).Thisreviewcommittee
determines whether or not the due care criteria of the
law were respected and sends the case to the judicial
authorities when irregularities are found.
913
Since legalisation of euthanasia in Belgium, the
reviewcommitteehaspublishedthreebiennialreports
covering all reported cases of euthanasia.
14-17 Accord-
ingtothesedocuments,physicianswhoreportedcases
practised euthanasia carefully and in compliance with
the law, and no cases of abuse have been found. How-
ever, concerns exist that only cases of euthanasia
that are dealt with carefully are being reported.
18
Whethercasesthatarenotreportedtotheofficialreview
system are dealt with equally carefully is uncertain.
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have been conducted using a representative sample of
death certificates to identify instances where a defini-
tion of euthanasia was met but the case was not
reported to the authorities. These studies have shown
that although reported and unreported cases of eutha-
nasia did not differ according to patient characteristics
and clinical conditions, physicians responsible for the
unreported cases were less likely to have consulted a
second physician or written a report on the
decision.
1920 The reporting rate in the Netherlands
has gradually increased from 18% in 1990 to 80.2% in
2005, indicating a trend towards more societal control
over the practice.
21 Most euthanasia cases that are not
reported in the Netherlands are performed with
opioids or sedatives and are often not perceived as
euthanasia by the physicians themselves.
2021
TherateatwhichphysiciansinBelgiumreportcases
of euthanasia is unknown, and differences between
reported and unreported cases have not been investi-
gated. In this large scale study of death certificates, we
estimate the rate of reporting of euthanasia cases in
Flanders, the Dutch speaking part of Belgium, to the
federal review committee. We investigate the relation
between reporting and non-reporting of euthanasia
and the characteristics of the physician and patient,
the time by which life was shortened as estimated by
the physician, and the labelling of the end of life deci-
sion by the physician involved. Finally, we study the
reasonsfornon-reporting,andcompareduecarechar-
acteristics of reported and unreported cases.
METHODS
Study design
WeperformedastudyofdeathcertificatesinFlanders,
Belgium, with the principal aim of estimating the inci-
denceofmedicalendoflifedecisionswithapossibleor
certain life shortening effect.
22 All deaths in Flanders
mustbereportedtothepropergovernmentauthorities
and death certificates issued. By studying death certifi-
cates we were able to use death as the unit of measure-
ment and reliably estimate the incidence and
characteristics of end of life decisions.
23 A stratified at
random sample of persons deceased in Flanders was
drawn by the Flemish Agency for Care and Health,
the central administration authority that handles
death certificates. All deaths of Flemish residents aged
1 year or more that took place in Flanders between 1
June 2007 and 30 November 2007 were included.
Deaths of Flemish persons that occurred outside of
Flanders, deaths that occurred in Flanders of persons
who were temporarily in Flanders but did not reside
there on a permanent basis (mainly deaths by acci-
dent), and deaths of persons younger than 1 year
were excluded.
To increase the reliability of the estimate of the total
number of euthanasia cases, we oversampled cases
where an end of life decision was more likely. Deaths
were grouped into one of four strata according to the
underlying cause of death on the death certificate and
thecorrespondingprobabilityofanendoflifedecision
being made. Stratum one contained all deaths where
an end of life decision was certain (that is, euthanasia
indicatedastheimmediatecauseofdeath);stratumtwo
contained all deaths from neoplasms (international
classification of diseases, 10th revision (ICD-10)
codes C and D00-D48) where medical assistance in
dyingwasprobable;stratumthreecontainedalldeaths
fromcauseswheremedicalassistanceindyingwaspos-
sible (ICD-10 codes E, F, G, J, K, and N); and stratum
four contained all deaths where medical assistance in
dying was improbable. All deaths in stratum one were
retained in the sample, whereas 50% of the deaths in
stratum two, 25% in stratum three, and 12.5% in stra-
tum four were included. This resulted in a sample of
6927 death certificates, which represents about 25% of
all deaths in the sampling period and about 12% of all
deaths in the whole of 2007. Data were weighted after-
wards to correct for the disproportionate stratification
of the underlying causes of death.
22
Everyphysicianwhohadreportedadeathwassenta
five page questionnaire. If the physician who received
the questionnaire was not the main treating physician,
he or she was asked to pass the questionnaire on to the
treating physician. To guarantee total anonymity of
physicians and patients, a lawyer was used as inter-
mediary between responding physicians, researchers,
andtheFlemishAgencyforCareandHealth.Weused
thetotaldesignmethodtooptimisetheresponserate.
24
Anintensivefollow-upmailingwasconductedincases
of non-response.
Deaths where physician response to the question-
naire was impossible were excluded—for example,
caseswherethephysiciancouldnotidentifythepatient
on the basis of the information in the letter or did not
have access to the patient file; cases where the certify-
ing physician was not the treating physician for the
patient in question; and cases where the identity of
the treating physician was unknown.
Positiverecommendationsfortheanonymityproce-
dureandstudyprotocolwereobtainedfromtheethical
review board of the University Hospital of the Vrije
Universiteit Brussel, the ethics committee of the Uni-
versity Hospital of Ghent University, the Belgian
NationalDisciplinaryBoardofPhysicians,andtheBel-
gian Federal Privacy Commission. The study design,
sampling, and mailing procedure are described in
detail elsewhere,
22 and the first results of this study
have previously been published.
25
Questionnaire
Thequestionnaire focused onthe characteristics of the
end of life decision making that preceded the patient’s
death. Terms such as “euthanasia” were not used
because they are subject to ambiguous and multidi-
mensional definition. Instead, four key questions
were used to more validly determine the types of deci-
sioninendoflifecare.Thequestionsassessedwhether
thephysicianhadtakenanyofthefollowingmeasures:
withholding or withdrawing medical treatment taking
into account a possible life shortening effect; intensify-
ing the alleviation of pain or other symptoms with a
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drawing medical treatment with the explicit intention
ofhasteningthe patient’sdeath; or administering, sup-
plying, or prescribing drugs with the explicit intention
of hastening the patient’s death. The act was classified
as euthanasia if the last of the four key questions was
answered affirmatively, the act was performed in
response to an explicit request of the patient, and the
physicianoranotherpersonotherthanthepatienthim-
self or herself had administered the drug. This defini-
tion of euthanasia corresponds to the legal definitions
of euthanasia in Belgium,
9 the Netherlands,
26 and
Luxembourg,
27 and to the definition of euthanasia
used by the European Association for Palliative Care
in its official position statement on euthanasia.
28 For
cases in which physicians responded affirmatively to
more than one of the four key questions, the act that
involved the most explicit intention with regard to the
hasteningofthepatient’sdeathwasusedtoclassifythe
act. When classifying cases of euthanasia, the adminis-
trationofdrugsprevailedoverthewithholdingorwith-
drawing of medical treatment for cases in which there
was no single most explicit intention.
Thequestionnairealsocontainedquestionsaboutthe
decisionmakingprocess,thetypeofdrugsused,andthe
lifeshorteningeffectofthe act, as estimated bythe phy-
sician. We also asked whether or not the physician had
reportedthecasetothereviewcommittee,and,ifappro-
priate, their reasons for non-reporting. Physicians were
further asked to choose the term that they thought
best described their act: alleviation of symptoms;
non-treatment decision;palliativeor terminal sedation;
or euthanasia.
Analysis
To estimate the reporting rate for euthanasia in Flan-
ders, two numbers are needed:
1) An estimate of the number of euthanasia cases
reported to the review committee (numerator)
2) An estimate of the total number of euthanasia
cases performed (denominator).
The survey of death certificates allowed us to esti-
mate the total number of euthanasia cases in Flanders
in 2007. To estimate the number of euthanasia cases
reported to the review committee, we used the ques-
tion that asked whether or not the physician had
reported the case to the review committee. The total
number of euthanasia cases reported to the review
committeeinBelgiumisactuallyknownfromthecom-
mittee reports,
14-16 but we chose not to use the official
datatocalculatethereportingratebecausetheydonot
allow us to distinguish with certainty the euthanasia
cases performed in Flanders from those performed in
Brussels or Wallonia, the other two parts of Belgium.
The classification “reported” or “unreported” was
made using the question whether or not the physician
had reported the case to the review committee.
The total number of euthanasia cases and the total
number of reported euthanasia cases were estimated
by weighting the sample for the disproportionate
stratification procedure and for non-response bias with
regard to age, sex, province, place, and cause of death,
making the numbers representative for all deaths in
Flanders in the study year. The weighting procedure
was done in three steps. In the first step, the data were
corrected for the disproportionate stratification proce-
dure by assigning to the cases a weight that was the
inverse of the sampling fraction of the stratum they
hadbeenassignedto.Wefoundproportionallylesshos-
pital deaths and more cancer deaths in the sample than
in the population (P<0.000). To correct for this differ-
ence, in a second step the sample was weighted on the
basisofplaceofdeathandcauseofdeathbydividingthe
numberofcasesinthepopulationbythesamplednum-
ber for each combination of these characteristics.
Finally, we found significant differences between
responding physicians and non-responding physicians
intheage,province,andplaceofdeathoftheirpatients.
We therefore calculated an additional weight by divid-
ing the sampled number of cases by the responding
number for every specific combination of these three
variables. The different weights resulting from the
three steps were combined into one overall weight.
After this procedure no significant differences were
found between the cases from responding physicians
and the population for sex, age, province, place, and
cause of death. The data are therefore representative
of the entire population. The weighting procedure was
done using binary logistic regression.
Differences in the distribution of characteristics
between reported and unreported cases of euthanasia
were tested by Fisher’s Exact test. P values that were
less than or equal to 0.05 were considered to indicate
statisticalsignificance.Statisticalcalculationswereper-
formedwithSPSSsoftwareversion16.0.Reliablemul-
tivariate models could not be made because of
multicollinearity.
RESULTS
Reporting rate for euthanasia
Thesurveyresponseratewas58.4 (3623/6202eligible
cases).Therewere6927deathsinthesample,ofwhich
725 were excluded because response for these cases
was impossible. There were thus 6202 eligible deaths
inthesample.Thenumberofcasesofeuthanasiainthe
sample according to the death certificates was 137.
Extrapolation on the basis of these 137 cases gave an
estimated total number of cases of euthanasia in Flan-
dersin2007of1040(95%CI970to1109;table 1).The
incidence of euthanasia in Flanders in 2007 was thus
estimated as 1.9% of all deaths (95% CI 1.6% to
2.3%).
25 Approximately half (549/1040 (52.8%, 95%
CI 43.9% to 60.5%)) of euthanasia cases were reported
to the review committee (that is, an estimated yearly
number of 549, 95% CI 426 to 672).
Reasons for not reporting a case of euthanasia
Thephysicianswhospecifiedthattheyhadnotreported
a case that the study defined as euthanasia (n=64 cases)
were asked about the reasons for non-reporting. For
76.7% of these cases, physicians answered that they
RESEARCH
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17.9% they gave the reason that reporting is too much
of an administrative burden, 11.9% that the legal due
care requirements had possibly not all been met, and
9%thateuthanasiaisaprivatematterbetweenphysician
and patient (8.7%). A small proportion (2.3%) did not
report the case because of possible legal consequences
(multiple answers were possible, not in tables).
Reporting of euthanasia according to characteristics of
physician and patient, time by which life was shortened,
and labelling of the end of life decision
General practitioners and specialists were equally
likely to report their cases of euthanasia to the review
committee (43/80 (53.8%) v 29/56 (51.8%); table 2).
Wefoundnorelationbetweenreportingofeuthana-
siaandthepatient’ssex,educationalattainment,living
situation, or place of death (table 2). However, in a
bivariate analysis there was a significant relation
between reporting of euthanasia and the patient’s
age, with deaths of patients aged 80 years or older
reportedsignificantlylessoftenthandeathsofyounger
patients (6/28 (21.4%) v 67/109 (61.5%); P=0.001).
Cases were also reported less often when the time by
which life was shortened was less than one week com-
pared with when the life shortening effect was greater
(27/73 (37.0%) v 42/57 (73.7%); P<0.001). These
bivariate relations did not hold after controlling for
labelling of the end of life decision (data not shown).
We asked all physicians who performed an act of
euthanasia as defined in our study to choose the term
that they thought best described the act. In 53.2%
(72/136 (one case missing data on this variable)) of all
cases, physicians chose the term “euthanasia.” In the
remaining cases the physicians chose a different label.
The reporting rate for cases that were labelled “eutha-
nasia” by the physician was 93.1%, whereas the report-
ing rate for cases labelled with a term other than
euthanasia was much lower (7.8% overall). A large
majority of the unreported cases (92.2%) involved acts
of euthanasia as defined in our study but were not per-
ceivedorlabelledas“euthanasia”bythephysician(data
not shown).
Differences between reported and unreported cases
A verbal as well as a written request for euthanasia was
present in 73.1% ofallreported cases,whereasa legally
required written request was absent in the majority of
unreported cases (87.7% verbal request only; P<0.001;
table 3). In reported cases, the decision to perform
euthanasia was always discussed with others, which
was not always the case in unreported cases (100% v
85.2%; P=0.001). Other physicians and care givers spe-
cialised in palliative care were consulted more often in
reportedcasesthaninunreportedcases(97.5%v54.6%;
P<0.001and63.9%v33.0%;P<0.001,respectively).No
differences were found between reported and unre-
ported cases for discussion of the decision to end the
patient’s life with nursing staff, relatives, or other per-
sons (P=0.864, P=0.841, and P=0.068, respectively).
Reported cases of euthanasia were almost always
performed with barbiturates, neuromuscular relax-
ants, or both (95.6%), whereas the majority of unre-
ported cases (90.5%) were performed with other
drugs, mainly opioids, sedatives, or both (P<0.001).
However, in about half (52.7%) of the unreported
cases in which opioids were used with the explicit
goal of hastening death, physicians indicated that
they did not administer a higher dose than necessary
for pain and symptom alleviation. In reported cases of
euthanasia,thedrugswerealmostalwaysadministered
by a physician (97.7% of cases); in unreported cases,
the drugs were often administered by a nurse alone
(41.3%; P<0.001). When drugs were administered by
a nurse alone, the agents used were always opioids or
sedatives (not in tables).
DISCUSSION
ThereportingrateforeuthanasiainFlandersin2007is
estimatedtobe52.8%.Thismeansthatonlyoneoutof
two cases of actual euthanasia is reported to and
reviewedbytheFederalControlandEvaluationCom-
mittee, and one in two is not. The most important rea-
son given by physicians for not reporting a case to the
review committee was that the physician did not per-
ceivetheacttobeeuthanasia(76.7%).Alargemajority
of the unreported cases (92.2%) were in fact acts of
euthanasia as defined in our study but were not per-
ceived or labelled as “euthanasia” by the physician
involved. Unreported cases of euthanasia were gener-
allydealtwithlesscarefullythanreportedcases:awrit-
tenrequestforeuthanasiawasabsentmoreoften;other
physiciansandcaregiversspecialisedinpalliativecare
were consulted less often; the life ending act was more
often performed with opioids, sedatives, or both; and
the life ending drugs were more often administered by
a nurse instead of a physician.
Strengths and limitations of study
This study is the first in Belgium to estimate the rate at
which euthanasia is reported to the federal authorities
and to study the differences between reported and
unreported cases. We followed the same robust study
design as in our previous studies
2930: we drew a large
representative sample of death certificates; used
Table 1 |Reporting rates for euthanasia in Flanders, Belgium, in 2007
Number of
cases Rate
Estimated number of cases of euthanasia 137 —
Estimated number of reported cases of euthanasia 549 —
Estimated weighted total number of cases of euthanasia* 1040 1.9% (1.6% to 2.3%)†
Overall reporting rate for euthanasia‡ 52.8% (43.9% to 60.5%)†
Reporting rates for euthanasia according to drug use‡§
Recommended drugs¶ 70 92.9% (84.3% to 96.5%)
Non-recommended drugs** 61 4.8% (1.1% to 16.9%)
*The estimated total rate of euthanasia was calculated by weighting for stratification and for patient and
mortality characteristics of all deaths in 2007.
25 The original number of euthanasia cases in the sample was
137. One case was missing data on the variable “reporting of end of life decision.”
† †Percent of all deaths in Flanders, Belgium, 2007.
25
‡Weighted percentage.
§Five “missings” on the variable “drugs used for euthanasia.”
¶Barbiturates, neuromuscular relaxants, or both.
**Opioids, benzodiazepines, or other drugs other than barbiturates or neuromuscular relaxants.
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procedure to guarantee total anonymity for patients
and physicians.
This study also has some limitations. The response
rate was only 58%, so the possibility that the results
could have been different had the response rate been
higher cannot be excluded. We therefore urge caution
in interpreting the results. Furthermore, the study is
based on self reporting by physicians. It is possible
that they did not remember all aspects of a case well,
and we cannot exclude a social desirability bias, espe-
cially for the question of whether or not the physician
had reported the case to the review committee. Unfor-
tunately,becausedeathcertificatedatafor2007arenot
yet available for Wallonia, the French speaking part of
Belgium,we couldnot estimatea reportingrateforthe
wholecountry.Ourfindingscannotbeextrapolatedto
the French speaking part of Belgium, in particular
because research has shown that end of life practices
differintheFrenchspeakingandtheFlemishspeaking
regions and because there may be a difference in will-
ingness to report cases of euthanasia owing to cultural
differences.
3132Anon-responsebiascannotbecomple-
tely excluded, although our non-response survey did
not point to that possibility.
Study interpretation
Five years after the enactment of the euthanasia law in
2002, half of all euthanasia cases in Flanders were
reported to the review committee. A similar reporting
procedureexistsintheNetherlands,wherethecurrent
reporting rate is estimated at 80.2%.
21 However, the
Netherlands had already experienced two decades of
relatively open euthanasia practice before euthanasia
was officially legalised in 2002, and a reporting proce-
dure has been in place since the early 1990s.
1333 Com-
paredtotheNetherlands,bringinglifeendingactsinto
the open is a relatively new experience for physicians
in Flanders (and in Belgium as a whole) because phy-
sicians have only been required to report cases since
the enactment of the euthanasia law.
1334 This may, at
least in part, explain the lower reporting rate in Flan-
ders compared with in the Netherlands. Another pos-
sible explanation could be that a higher number of
unclear cases of euthanasia—in which opioids, seda-
tives, or both are used to hasten death instead of neu-
romuscular relaxants—occur in Flanders than in the
Netherlands and that there are more cases in which
the estimated term of life shortening is small.
21 These
less clear cut cases of euthanasia are often not per-
ceived as euthanasia by the physicians and are conse-
quently not being reported.
The considerable distance between the legal defini-
tion of euthanasia and the perception of the physician
ofwhetheranactwaseuthanasiacouldbeexplainedby
three possible coinciding hypotheses.
A first hypothesis suggests that when a patient
requests that their life be ended and the physician in
response disproportionally increases the opioid or
sedative dose instead of administering neuromuscular
relaxants, the distinction between euthanasia and nor-
mal compassionate intensification of symptom treat-
ment is blurred. The confusion that may arise might
mean that physicians do not perceive the life ending
decision as euthanasia.
35 This would also explain why
drugs are in these cases often administered by a nurse
Table 2 |Reporting of euthanasia according to characteristics of physician and patient, time
by which life was shortened, and labelling of the end of life decision*
All cases
(n=137;
weighted n)†
Cases reported to review committee
(n=72)
P value‡
Weighted
n
Weightedpercentageofcases
(95% CI)
Physician characteristic
Type of physician
General practitioner 80 43 53.8 (41.5 to 65.4) 0.863
Specialist 56 29 51.8 (34.3 to 69.1)
Patient characteristic
Sex
Male 83 43 51.8 (38.3 to 64.9) 0.727
Female 54 30 55.6 (39.3 to 70.0)
Age
18-49 12 8 66.7 (31.7 to 90.0) 0.001§
50-64 37 23 62.2 (42.2 to 77.8)
65-79 60 36 60.0 (45.3 to 72.8)
≥80 28 6 21.4 (9.1 to 40.4)
Educational attainment
Primary school 20 7 35.0 (13.1 to 64.4) 0.309
Lower secondary school 40 24 60.0 (41.2 to 75.8)
Higher secondary school or higher 37 21 58.8 (37.5 to 75.0)
Unknown 41 21 51.2 (35.1 to 67.9)
Living situation
Alone 24 15 62.5 (40.6 to 80.5) 0.432
In private household 98 50 51.0 (39.1 to 63.0)
In institution 10 4 40.0 (9.9 to 83.3)
Place of death
Home 66 37 56.1 (43.3 to 68.3) 0.874
Hospital 59 30 50.8 (34.1 to 67.6)
Care home 5 2 40.0 (13.3 to 77.8)
Other 6 3 50.0 (7.6 to 91.4)
Diagnosis
Malignant disease 111 58 52.3 (42.3 to 61.9) 0.002§
Cardiovascular disease 5 0 0.0 (0.0 to 0.0)
Disease of the nervous system 7 6 85.7 (34.3 to 98.1)
Disease of the respiratory system 6 2 33.3 (4.5 to 85.9)
Other disease 5 5 100.0 (100 to 100)
Shortening of life
<24 hours 13 2 15.4 (4.8 to 40.1) <0.001§
1-7 days 60 25 41.7 (27.6 to 57.5)
1-4 weeks 35 21 60.0 (35.1 to 80.5)
1-6 months 16 16 100.0 (100 to 100)
>6 months 6 5 83.3 (44.0 to 98.8)
Labelling of the end of life decision
Euthanasia 72 67 93.1 (85.1 to 96.6) <0.001§
Palliative or terminal sedation 48 2 6.3 (1.5 to 21.6)
Non-treatment decision 8 2 25.0 (1.8 to 78.6)
Alleviation of symptoms 8 0 0.0 (0.0 to 30.1)
*Percentages are row percentages. All percentages and total numbers are adjusted for stratification, and to
patient/mortality characteristics of all deaths in 2007, which makes the percentages representative for all
deaths in Flanders in 2007. Total numbers may not always amount to 137 because of rounding or missing
values on variables. Percentages may not always amount to 100 because of rounding.
† †One case was missing data on the variable “reporting of end of life decision.”
‡P value for reported cases versus cases not reported.
§P<0.05 using Fisher’s Exact (Monte Carlo).
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sia law. This hypothesis is supported by findings from
another study that has shown that some physicians see
a “grey area,” or continuum, between palliation and
euthanasia and find that the distinctions between the
two are not always clear cut.
35 The fact that some of
the physicians in our study indicated that their use of
opioids, sedatives, or both had the explicit intention of
hastening death, yet at the same time indicated they
had not used a higher dose than necessary to alleviate
pain and other symptoms, may be an indication of the
confusion that can arise in these situations. Although
thephysiciansinourstudyhadtheintentionofhasten-
ing death and believed that death was the result of
using these drugs, it is possible that some may have
overestimated the actual life shortening effect of the
drugs they administered.
A second proposed hypothesis is one of reducing
cognitive dissonance. Some physicians may on the
onehandfeelreluctanttoperformeuthanasiaorfollow
the requirements of the euthanasia law, while on the
otherhandwanttohelpthepatientwhorequestseutha-
nasia. To reduce this cognitive dissonance, they may
choose to use opioids or sedatives because these drugs
are not normally associated with euthanasia. Research
has also shown that this kind of life ending practice
might be more psychologically acceptable to physi-
cians than euthanasia by bolus injection.
36 By disguis-
ing the end of life decision as normal medical practice,
whetherdeliberatelyornot,physiciansmightfeel they
have granted their patient’s wish without in their eyes
having performed real euthanasia and without having
to comply with the euthanasia law.
Opioids and sedatives are used to perform euthana-
siamoreofteninpatientsolderthan80thaninyounger
patients, which may indicate that physicians are per-
haps more reluctant to perform euthanasia in elderly
patients. Research from the Netherlands has shown
that requests for euthanasia from older patients are
often refused.
37 There are strong positive associations
with refusing a request where the patient is not fully
competentandwherethereisalesserdegreeofunbear-
able and hopeless suffering.
37 It is possible that physi-
cians find that older patients’ requests or suffering are
not explicit enough to merit what is in their eyes real
euthanasia by bolus injection.
Table 3 |Characteristics of due care for reported and unreported cases of euthanasia*
All cases (n=137)‡
Cases reported to review committee
(n=72) Unreported cases (n=64)
P value Weighted n
Weighted percentage of
cases (95% CI) Weighted n
Weighted percentage of
cases (95% CI) Weighted n
Weighted percentage
of cases (95% CI)
Type of request for euthanasia
Verbal request only 68 50.0 (40.1 to 60.5) 13 17.6 (9.1 to 31.5) 55 87.7 (76.6 to 93.9) <0.001†
Written request only 9 6.6 (2.3 to 18.0) 7 9.3 (2.4 to 29.9) 2 3.7 (0.9 to 14.5)
Verbal and written request 58 43.3 (33.5 to 53.1) 53 73.1 (56.8 to 84.9) 5 8.6 (3.9 to 18.0)
Decision discussed with others‡ ‡
Total 126 93.3 (80.2 to 97.8) 72 100 (100 to 100) 54 85.2 (63.0 to 95.1) 0.001†
Other physician 106 77.0 (66.2 to 85.7) 71 97.5 (88.1 to 99.5) 35 54.6 (38.7 to 69.6) <0.001†
Caregiverspecialisedinpalliativecare 67 49.1 (39.2 to 59.6) 46 63.9 (49.6 to 76.2) 21 33.0 ( 21.3 to 47.2) <0.001†
Nursing staff 72 53.5 (42.8 to 63.3) 39 54.3 (40.5 to 67.5) 33 51.9 (36.6 to 66.9) 0.864
Relative 106 77.5 (66.0 to 85.8) 57 78.4 (63.6 to 88.4) 49 76.2 ( 57.4 to 88.4) 0.841
Other persons 8 5.9 (2.9 to 11.9) 7 9.1 (4.2 to 18.7) 1 2.3 (0.3 to 15.0) 0.068
Drug used for euthanasia
Neuromuscular relaxant§ 15 11.2 (6.5 to 18.9) 15 22.1 (12.8 to 35.0) 0 — <0.001†
Barbiturate¶ 21 15.7 (10.5 to 23.2) 18 26.5 (16.6 to 38.5) 3 4.8 (1.8 to 13.0)
Neuromuscular relaxant and
barbiturate**
34 26.6 (17.7 to 36.8) 32 47.1 (34.0 to 61.9) 2 3.2 (1.0 to 10.3)
Opioids†† 60 45.5 (35.5 to 56.4) 3 4.4 (1.0 to 15.4) 57 90.5 (80.2 to 94.8)
Other drug 1 1.0 (0.2 to 4.1) 0 — 1 1.6 (0.5 to 8.3)
Person who administered the drug
Physician 96 72.2 (60.8 to 81.0) 69 97.9 (86.5 to 99.7) 27 43.0 (29.0 to 58.3) <0.001†
Nurse 26 19.3 (11.7 to 30.4) 0 — 26 41.3 (26.3 to 57.5)
Physician and nurse 9 7.4 (3.2 to 16.2) 1 2.1 (0.3 to 13.5) 8 13.4 (5.3 to 29.7)
Physician and other person 2 1.2 (0.3 to 4.8) 0 — 2 2.6 (0.6 to 10.0)
*All percentages are adjusted for stratification and for patient and mortality characteristics of all deaths in 2007, which makes the percentages representative for all deaths in Flanders in
2007.
† †P<0.05, using Fisher’s Exact (Monte Carlo).
‡One case was missing data on the variable “reporting of end of life decision.” Total numbers may not always amount to 137 because of rounding or missing values on variables.
Percentages may not always amount to 100 because of rounding.
§ Neuromuscular relaxant alone or in conjunction with benzodiazepine, opioids, or other drug other than barbiturate.
¶ ¶Barbiturate alone or in conjunction with benzodiazepine, opioids, or other drug other than muscle relaxant.
**Neuromuscular relaxant and barbiturate, alone or in conjunction with benzodiazepine, opioids, or other drug.
††Opioids alone or in conjunction with benzodiazepine or other drug other than barbiturate or neuromuscular relaxant.
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sure. Our results indicate that unreported cases
involved a shorter period by which life was shortened.
It is plausible that, in cases in which the patient is
obviously in a lot of pain and then requests euthanasia,
thephysicianmayfeelunderpressuretohelpthepatient
as soonaspossible.Heorshecouldthenbeginthe pro-
cess of euthanasia, but this process can be experienced
as too time consuming or burdensome. The physician
may in these circumstances prefer to use opioids or
sedativesbecausethesedrugsaremorereadilyavailable
andthereislesscontrolovertheirdistributionthanwith
neuromuscular relaxants. By disguising euthanasia as
painalleviation,physicianscanproceedwiththeeutha-
nasia process without having to comply with the strin-
gent, and in their perception time consuming,
procedures of the euthanasia law.
We found a strong relation between a priori consul-
tation of other physicians and the reporting of eutha-
nasia. Consultation occurred in almost all reported
cases,whereasitoccurredinonlyhalfofallunreported
cases. This association was also found in the
Netherlands,
3839 where the most important reason for
not consulting was that the physician did not intend to
report the case. Physicians who intend to report a case
seemtoconsultanotherphysicianandcomplywiththe
otherrequirementsofthelaw,whereasphysicianswho
do not intend to report a case appear to consult a phy-
sicianonlywhentheyfeeltheneedfortheopinionofa
colleague.
39 In the Netherlands, the availability of a
service of expert consultants has had a positive influ-
ence on the reporting rate of euthanasia.
38 A similar
service was developed in Flanders,
40-42 and it is likely
thatsuchservices,inincreasingphysicians’knowledge
of euthanasia, may help increase the reporting rate.
Conclusions and policy implications
The quality of medical practice at the end of life needs
monitoringinanykindofsociety,andcertainlyincoun-
tries that have legalised euthanasia. To provide better
societalcontrolovereuthanasiaandsafeguardthequal-
ity of the practice, it is necessary that all cases of eutha-
nasia are reported. The transparency in reporting that
was envisagedbythe architectsofthe euthanasia law in
Belgium extends especially to those cases in which the
time bywhichlifeisshortened isgreater than one week
and to those cases in which it is more certain that life is
shortened by the drugs administered. However, this
study estimated that in 2007 only half of all cases of
euthanasia in Flanders and around three in four where
life was shortened by more than one week were
reported to the review committee.
Assuchlegalisationalonedoesnotseemsufficientto
reachthegoaloftransparency(“total”ora100%trans-
parencyseemstobearatherutopianideal)andtoguar-
antee the careful practice of euthanasia. It seems
warranted that a policy be developed to facilitate phy-
siciansincomplyingcorrectlywitharequestforeutha-
nasia,includingtheirobligationtoreport.Educationin
medicalschoolsandadequatesupportfortreatingphy-
sicians who are confronted with an explicit request for
euthanasia will be pivotal in reaching that goal.
Thepossibilityofsocietalcontrolovertheeuthanasia
practiceisanimportantprerequisiteforeffective eutha-
nasia legislation. By estimating the reporting rate for
euthanasia in a country that has legalised the practice
and by investigating reasons for non-reporting, our
study offers valuable data driven information that can
inform the debates about the legalisation of euthanasia
that are currently going on in the United Kingdom and
in many other countries.
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